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Global health has been an issue of seemingly low political importance in comparison with issues that have direct bearing on countries’
national security. Recently, health has experienced a ‘‘political revolution’’ or a rise in political importance. Today, we face substantial global
health challenges, from the spread of infectious disease, gaps in basic maternal and child health care, to the globalization of cancer. A recent
estimate states that the ‘‘overall lifetime risk of developing cancer (both sexes) is expected to rise from more than one in three to one in two
by 2015.’’ These issues pose significant threats to international health security. To successfully combat these grave challenges, the inter-
national community must embrace and engage in global health diplomacy, defined by scholars Thomas Novotny and Vicanne Adams as
a political activity aimed at improving global health, while at the same time maintaining and strengthening international relations. The IAEA
(International Atomic Energy Agency) is an international organization with a unique mandate to ‘‘accelerate and enlarge the contribution of
atomic energy to peace, health, and prosperity throughout the world.’’ This article discusses global health diplomacy, reviews the IAEA’s
program activities in human health by focusing on radiation medicine and cancer, and the peaceful applications of atomic energy within the
context of global health diplomacy.Resume
Comparativement aux enjeux qui ont une incidence directe sur la securite des pays, la sante mondiale a longtemps reve^tu une faible
importance politique. Toutefois, la sante a recemment ete le thea^tre d’une « revolution politique » qui s’est manifeste par une hausse de son
importance politique. Nous sommes aujourd’hui confrontes a des problemes de sante majeurs a l’echelle mondiale, qu’il s’agisse de la
propagation de maladies infectieuses, des lacunes en matiere de soins de sante des meres et des enfants ou encore de la mondialisation du
cancer. Selon une etude recente, le risque de developper un cancer au cours de la vie devrait augmenter pour les deux sexes d’ici 2015 (d’un
ratio de un sur trois a un sur deux), ce qui pose de serieuses menaces a la securite sanitaire mondiale. Pour lutter efficacement contre ces
problemes, la communaute internationale doit souscrire pleinement a la diplomatie en sante mondiale, que Thomas Novotny et Vicanne
Adams definissent comme l’activite politique visant a ameliorer la sante mondiale, tout en preservant et renforc¸ant les relations inter-
nationales. L’Agence internationale de l’energie atomique (AIEA) est un organisme international qui a pour mandat de « ha^ter et accro^ıtre la
contribution de l’energie atomique a la paix, la sante et la prosperite dans le monde entier ». Le present article traite de la diplomatie en sante
mondiale et examine les activites de l’AIEA au chapitre de la sante humaine. Il s’interesse plus particulierement a la medecine des
rayonnements et au cancer, ainsi qu’aux applications pacifiques de l’energie atomique dans un contexte de diplomatie en sante mondiale.
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Traditionally, global health has been an issue of seem- the developing world was a threat to international peace and
ingly low political importance in comparison with issues that
have direct bearing on countries’ national security. Recently,
health has experienced a ‘‘political revolution’’ [1] or a rise
in political importance. In the year 2000, the United Nations
(UN) declared that human immunodeficiency viruseAIDS in* Address for correspondence: Thomas Neil Pascual, MD, Wagramer-
strasse 5, PO Box 100, 1400, Vienna, Austria.
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doi:10.1016/j.carj.2011.12.001security, which marked the first time that a health issue was
discussed before the UN Security Council [2]. In that same
year, UN Member States (MS) (membership in the Organi-
zation, according to the Charter of the UN, ‘‘is open to all
peace-loving States which accept the obligations containedE-mail address: T.Pascual@iaea.org (T. N. Pascual).
ll rights reserved.
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tion, are able to carry out these obligations’’ [3] adopted the
Millennium Declaration and set 8 Millennium Development
Goals in response to central development challenges around
the world. In 2007, the Ministers of Foreign Affairs of Brazil,
France, Indonesia, Norway, Senegal, South Africa, and
Thailand signed the Oslo Ministerial Declaration, which
called for the scope of foreign policy to include health [4].
Today, we face substantial global health challenges from
the spread of infectious disease, gaps in basic maternal and
child health care to the globalization of cancer. A recent
estimate states that the ‘‘overall lifetime risk of developing
cancer (both sexes) is expected to rise from more than one in
three to one in two by 2015’’ [5]. These challenges pose
significant threats to international health security. According
to the World Health Organization (WHO), ‘‘international
health security is the first line of defense against health
shocks that can devastate people, societies and economies
worldwide’’ [6]. To successfully combat these grave chal-
lenges, the international community must embrace and
engage in global health diplomacy. ‘‘Diplomacy is the art
and practice of conducting international relations’’ [7].
Scholars define global health diplomacy as a political activity
aimed at improving global health, while at the same time
maintaining and strengthening international relations,
particularly in developing countries [8]. The origins of
modern health diplomacy date back to the First International
Sanitary Conference of 1851, when diplomats, scientists, and
medical doctors met in Paris in response to the outbreak of
cholera in Europe [9]. The Conference was organized with
the aim of coordinating country strategies for controlling
disease, while at the same time, ensuring that the coordinated
plans would not affect international trade. The Conference
represents the origin and development of international
cooperation for health and led to the creation of the WHO.
The International Atomic Energy Agency (IAEA) is an
international organization with a unique mandate, to
‘‘accelerate and enlarge the contribution of atomic energy to
peace, health, and prosperity throughout the world’’ [10].
The IAEA’s Division of Human Health (NAHU) promotes
and supports peace among nations through a common mutual
interest in health. This article focuses on cancer as a threat to
international security, defines and introduces global health
diplomacy as a means to overcome global challenges, and
briefly outlines the IAEA’s program activities and peaceful
applications of atomic energy in human health (by focusing
on cancer) within the context of health diplomacy.
Cancer and Health Diplomacy
Today, cancer ranks as the second-leading cause of death
and disability in the entire world (after heart disease) [11]
and kills more people than human immunodeficiency
viruseAIDS, tuberculosis, and malaria combined. Cancer is
one of the biggest killers of both adults and children in the
developing world; it is estimated that, in developing countries,
approximately 655 people with cancer die per hour [11].According to the International Union against Cancer (UICC)
and theWHO, approximately 40% of cancers are preventable.
Radiation medicine plays an indispensable role in the
management of cancer; although everyday applications of
radiation medicine help millions of patients worldwide, less
than 25% of cancer patients in low- and middle-income
countries have access to radiotherapy treatment. The Pro-
gramme of Action for Cancer Therapy was launched in 2004
in response to the growing cancer crisis in the developing
world. The IAEA established this joint program on cancer
control with WHO to manage an effectively coordinated
approach to cancer in low- and middle-income countries.
The Oslo Declaration expressed countries desire and
determination to ‘‘better integrate their health and diplomatic
agendas’’ [12]. Health diplomacy seeks to unite diplomats,
physicians, health professionals, scientists, academics, and
nongovernmental organizations based on a shared desire to
promote health and to better understand common interests of
health in foreign policy. Through global health diplomacy,
relations and ties among states can be strengthened and
renewed, new allies can be made, and the health situation
around the world can be improved. According to the San
Francisco Medical Society, the root cause of health crises is
often political, especially in conflict settings. Medicine can
‘‘provide the first steps towards bridging cultural gaps, not
only to alleviate human suffering, but to defuse international
conflict’’ [13]. To bridge gaps, political and resource
commitment is necessary.
When taking into consideration the important relationship
between health and foreign policy, ‘‘today’s global health
professionals need to be diplomats as well as providers,
investigators, and managers’’ [13]. In a recent report from the
Global Health Policy Center at the Center for Strategic and
International Studies, more countries are looking to influence
the global health agenda and at the same time are seeking to use
health ‘‘as a means to solidify their political influence’’ [12].
‘‘Health diplomacy occupies the interface between inter-
national health assistance and international political relations.
Itmay be defined as a political change agent thatmeets the dual
goals of improving global health while helping repair failures
in diplomacy, particularly in conflict areas and resource-poor
countries’’ [13]. In response to the fact that cancer has
‘‘reached epidemic proportions’’ [14], the IAEA, under the
new director general, Mr Yukiya Amano, has made cancer one
of the top priorities on the Agency’s agenda. In collaboration
with MS and other international organizations, the IAEA is
striving to overcome cancer as its main health challenge.
IAEA Mechanisms for Transferring Technology in
Radiation Medicine
The IAEA has multiple mechanisms for transferring
technology to the MS. It brings together scientists and
experts from both developing and developed MS countries to
exchange knowledge and techniques while working together
on areas of common interest, such as the role of nuclear
technology in human health.
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Research Projects, which foster collaborative research activ-
ities between participating developed and developing MS;
meetings of advisory experts and consultants to advise the
Agency on specific topics for research; creation of publica-
tions and manuals, including educational materials and crea-
tion of databases for research purposes; the organization of
training courses and workshops; selection of experts for
thematic fact-finding missions; and the evaluation of fellow-
ship requests and subsequent placement. A large portion of
these are related to the so-called Technical Cooperation Pro-
grammes, which are requested by MS themselves. In this
context, the role of the professionals in the IAEA is to appraise
Technical Cooperation project requests from MS as it would
be expected from an independent ‘‘referee.’’ Considerable
attention is given to human resources capacity building
through education and training activities to facilitate sustain-
ability, which remains one of the most relevant issues of the
long-term success of projects. To this purpose, training courses
are organized, including the preparation of syllabi, selection of
lecturers and students, and undertaking considerable active
lecturing tasks [15]. The IAEA also provides MS with tech-
nical expertise and infrastructure development through
national and regional projects, which provide the necessary
equipment to establish and maintain technical facilities [16].
Focus on the NAHU
With a mandate to accelerate and enlarge the contribution
of atomic energy to peace, health, and prosperity throughout
the world, the IAEA actively works to incorporate health into
the policy agendas of MS and uses health diplomacy to
combat challenges around the globe. Through peaceful
applications of nuclear technology under the IAEA mandate
and program activities that reflect MS needs, NAHU works
to enhance countries’ abilities to address issues that deal with
the diagnosis and treatment of various health problems. With
expertise in diagnostic imaging (DI), nuclear medicine
(NM), and radiotherapy, the IAEA (through NAHU) focuses
on radiation medicine to manage noncommunicable diseases,
for example, cancer, with its largest contribution in diag-
nosis, screening, and radiotherapy [17]. The Agency’s
program activities in radiation medicine are carried out
through its subprograms, namely NM and DI, dosimetry and
medical radiation physics (DMRP), and applied radiation
biology and radiotherapy (ARBR).NM and DINuclear imaging and molecular biology provide data that
help characterize disease and improve diagnosis. NM
imaging techniques such as positron emission tomography
(PET) and single photon emission CT have proven to be
reliable tools for discovering blood cell disorders and
tumours as well as diagnosing and treating cancer. The IAEA
also uses radiopharmaceutical therapy to treat certain types
of cancer, for example, cancer of the liver.The IAEA NM and DI sections work to enhance MS
abilities to address important health problems, especially
cancer and cardiovascular diseases, through the use of NM
functional studies and therapy, including DI and molecular
biology techniques. The section’s objective is to establish
effective use of in vivo NM procedures in the management of
noncommunicable diseases. Through various projects, the
section updates old and implements new NM practices in
MS, with the aim of helping countries overcome challenging
health issues.
Through project ‘‘Clinical PET/CT,molecular imaging and
multimodality approach in diagnosis and control of disease,’’
the IAEA aims to establish effective use of molecular imaging
by using PET in the management of oncologic and cardio-
vascular disorders, and strengthen the capability to use the
multimodality (including CT) for the diagnosis of non-
communicable diseases, for example, cancer, inMS. In Project
‘‘Improvement of secondary prevention in ischemic heart
disease through strengthening the use of nuclear cardiology
techniques,’’ the IAEA works to enhance the effective use of
appropriate nuclear cardiology procedures in MS.DMRPRadiation dosimetry is necessary for the effective use of
radiation in medicine, including, for example, the treatment
of cancer by using radiotherapy and for clinical diagnostic
radiology (IAEA, DMRP Section). The DMRP section is
responsible for ensuring safety, effectiveness, and quality
assurance in the use of radiation medicine. The section aims
to enhance the capability of MS to achieve and, more
importantly, maintain a high level of quality and consistency
in radiation measurements and dosimetry standards used in
radiotherapy, DI, and radiation protection.
The DMRP subprogram activities are divided into
4 projects: ‘‘Quality audits in dosimetry for radiation medi-
cine,’’ ‘‘Radiation metrology supporting the network of
Secondary Standards Dosimetry Laboratories,’’ ‘‘Quality
assurance and guidelines for medical physics in the optimi-
zation of clinical radiation imaging,’’ and ‘‘Quality assurance
and medical physics developments in radiotherapy and
therapeutic nuclear medicine.’’
In issues that relate to radiotherapy, the section is involved
in efforts to ensure the quality of the entire dosimetric chain
through activities that include publishing guidance docu-
ments, supporting clinical audits, providing targeted exper-
tise or equipment, and offering a thermoluminescent
dosimetry dose audit service, which provides radiotherapy
centres an independent and external opportunity for verifi-
cation of the dose delivered to the patients during radio-
therapy treatments.
DMRP also establishes and sustains high-quality medical
imaging capability for diagnosis and related treatment in MS
that follow standards in quality assurance and safety at the
hospital in areas of diagnostic radiology and NM. These
efforts are supported by the creation of documents that
address the needs of the community; educational material,
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guidelines; and the funding of international coordinated
research projects, fellowships, and courses.ARBRAccording to the ARBR subprogram at the IAEA, radio-
therapy is a vital and cost-effective factor in the curative and
palliative treatment of cancer. ARBR deals with the clinical
and medical use of radiation through the use of sealed radio-
active sources for improving themanagement and treatment of
cancer in low- and middle-income countries. The following
ARBR projects pertain to palliative radiotherapy, curative
radiotherapy, and the use of advanced techniques in treating
cancer: ‘‘Palliative cancer management using radiotherapy,’’
‘‘Curative cancer management using radiotherapy,’’
‘‘Advanced techniques for cancer radiotherapy,’’ and ‘‘Bio-
logical effects of ionising radiation.’’
The subprogram works to improve the availability and safe
use of effective palliative, curative, and cancer management
strategies by establishing and/or upgrading radiotherapy
centre equipment as well as teaching and conducting training
courses for oncologists. In collaboration with IAEA MS, the
Section works to create sound policies on the delivery of
radiotherapy and cancer treatment; strives to ensure that
current and future cancer treatment technologies are operated
in an effective, efficient, and safe manner; and enhances the
capability of MS in preventing and controlling health effects
of radiation, and establishing sound program in radiation
sterilization in tissue banking [18].
Conclusion
As stressed by the Oslo Ministerial Declaration, which
calls for the scope of foreign policy to include health, and, in
combination with the IAEA’s mandate, the IAEA is
constantly striving for health to be more included in the
foreign policy agendas of states. Through the peaceful
application of nuclear technology and the identification of
areas of intervention and MS needs, the division of Human
Health of the IAEA works to enhance countries’ abilities to
address issues that deal with the prevention, diagnosis, and
treatment of various health problems. With expertise in
radiotherapy and NM, the IAEA focuses on radiation
medicine to manage noncommunicable diseases, especially
cancer. The IAEA has taken a leadership role in the fight
against cancer, having recently made cancer a priority on its
agenda. Still, it is up to the international community, namely
UN MS, International Organizations, and nongovernmental
organizations to cooperate in achieving the current Millen-
nium Development Goals, and to rally in favor of cancer
becoming the ninth goal [5]. To successfully combat global
challenges, for example, cancer, we must embrace and
engage in global health diplomacy, the art of improving
health and simultaneously strengthening international rela-
tions between states, and understanding health diplomacy as
a ‘‘bridge for peace and security’’ [13], as well as a tool foraccomplishing health equity, development, and international
health security.
References
[1] Fidler DP. Health as foreign policy: between principle and power.
Whitehead J Diplomacy Int Relat 2005;6:179e94.
[2] Luo RF. Understanding the threat of HIV/AIDS. JAMA 2002;288:
1649.
[3] United Nations. Member states: about UN membership. United
Nations. Available at: http://www.un.org/en/members/about.shtml.
Accessed May 28, 2011.
[4] Ministers of Foreign Affairs of Brazil France, Indonesia, Norway,
Senegal, South Africa, and Thailand. Oslo Ministerial Declaration
dglobal health: a pressing foreign policy issue of our time. Lancet 2007;
369:1373e8.
[5] Economist Intelligence Unit. Cancer Facts: Breakaway: the global burden
of cancerdchallenges and opportunities. 2009. Available at: http://
graphics.eiu.com/marketing/pdf/EIU_LIVESTRONG_Global_Cancer_
Burden.pdf. Accessed October 14, 2010.
[6] World Health Organization. World Health Day 2007: international
health security. World Health Organization. Available at: http://www.
who.int/world-health-day/previous/2007/en/index.html. Accessed
January 8, 2012.
[7] Feldbaum H, Michaud J. Health diplomacy and the enduring
relevance of foreign policy interests. PloS Med 2010;7:e1000226.
[8] Novotny TE, Adams V. Global Health Diplomacy: A Global Health
Sciences Working Paper. UCSF Global Health Sciences. Available at:
http://essentialsurgery.ucsf.edu/pdf/GH_DiplomacyWorkingPaperFINAL.
pdf. Accessed January 8, 2012.
[9] Geneva Foundation for Medical Education and Research. World
Health Organization: the mandate of a specialized agency of the
United Nations. Part 1: chapter 1. Geneva Foundation for
Medical Education and Research. Available at: http://www.gfmer.ch/
TMCAM/WHO_Minelli/P1-1.htm. Accessed January 8, 2012.
[10] International Atomic Energy Agency. Statute of the IAEA. Article II.
International Atomic Energy Agency. Available at: http://www.iaea.
org/About/statute_text.html. Accessed January 8, 2012.
[11] American Cancer Society. Global Cancer Facts & Figures. 2nd Ed.
Atlanta: American Cancer Society; 2011. Available at: http://www.
cancer.org/acs/groups/content/@epidemiologysurveilance/documents/
document/acspc-027766.pdf. Accessed online February 4, 2010.
[12] Bliss KE. Health Diplomacy of Foreign Governments. Center for
Strategic and International Relations, 2011. Available at: http://csis.org/
files/publication/110503_Bliss_HealthDiplomacy_web.pdf. Accessed
February 4, 2010.
[13] Novotny TE, Adams V. Global health diplomacy: a call for a new field of-
teaching and research. San Francisco Medical Society. 2008. Available at:
http://www.sfms.org/AM/Template.cfm?Section¼Article_Archives&
CONTENTID¼2272&TEMPLATE¼/CM/HTMLDisplay.cfm&SEC
TION¼Article_Archives. Accessed May 28, 2011.
[14] University of California, San Francisco. Global Health Sciences Initiative
in Health Diplomacy Web page. Available at: http://globalhealthsciences.
ucsf.edu/programs/diplomacy.aspx. Accessed May 28, 2011.
[15] DondiM,AndreoP.Developing nuclearmedicine in developing countries:
IAEA’s possible mission. Eur J Nucl Med Mol Imaging 2006;33:514e5.
[16] Leuker A, Ryan-Rappaport A, eds. PACT: Building Partnerships to
Fight the Cancer Epidemic. International Atomic Energy Agency,
September 2009. Available at: http://cancer.iaea.org/documents/
PACTBrochure_Small.pdf. Accessed October 14, 2010.
[17] International Atomic Energy Agency. Beyond the Invisible: Managing
Heart Disease and Cancer with Nuclear Science. International Atomic
EnergyAgency, 2006. p. 10.Available at: http://www.iaea.org/Publications/
Booklets/HeartDisease/beyondvisible.pdf. Accessed September 9, 2010.
[18] International Atomic Energy Agency. 2.2.3 (F.3) Radiation Oncology
and Cancer Management. Management Part of GC(53)/5. IAEA Major
Programme 2:209e17.
